Clinical value of thoracoscopic resection of single-station N2-Ⅲa nonsmall cell lung cancer
WANG Gang1 YE Yong-qiang1 XIE Bao-long1 YE Hua-bin1 CHEN Kai-xuan1 XIE Chuan-hua2
1.Department of Thoracic Surgery,Ganzhou Cancer Hospital,Jiangxi Province,Ganzhou 341000,China;
2.The First Department of Internal Medicine,Ganzhou Cancer Hospital,Jiangxi Province,Ganzhou 341000,China
Abstract:Objective To explore the clinical value of thoracoscopic resection of single-station N2-Ⅲa non-small cell lung cancer(NSCLC).Methods A total of 50 NSCLC patients admitted to Ganzhou Cancer Hospital from July 2017 to August 2020 were selected as the research subjects.According to a random number table,they were divided into a thoracoscopy group(n=25)and a thoracotomy group(n=25).Patients in the thoracoscopy group were treated with thoracoscopic lobectomy + systematic mediastinal lymph node dissection,and in the thoracotomy group,they were treated with thoracotomy lobectomy + systematic mediastinal lymph node dissection.The clinical indicators,pain degree and complications of the two groups were compared.Results The postoperative hospital stay of the thoracoscopy group was shorter than that of the thoracotomy group with statistical significance(P<0.05).The visual analogue scale score of the thoracoscopy group was lower than those of the thoracotomy group on the 1st day,3rd day,and 5th day after surgery.The total incidence of complications in the thoracoscopy group was lower than that in the thoracotomy group with statistical significance(P<0.05).There were no statistically significant differences in the intraoperative blood loss,operation time,time of indwelling drainage tube,and the amount of drainage and the number of lymph node dissections in the two groups(P>0.05).Conclusion Thoracic surgery for single-station N2-Ⅲa NSCLC has the advantages of less damage,milder pain and fewer complications.It is beneficial to speed up the postoperative recovery of patients,and is safe and reliable for the treatment of patients with single-station N2-Ⅲa NSCLC.